⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OSTX News
OS Therapies Incorporated
OS Therapies Announces FDA PDUFA Waiver & EMA Grants Union Marketing Authorisation Eligibility
newsfilecorp.com
OSTX
OS Therapies Announces Overall and Event Free Survival Key Subgroup Data for OST-HER2 in Recurrent, Fully Resected, Pulmonary Metastatic Osteosarcoma
newsfilecorp.com
OSTX
OS Therapies Receives Non-Proprietary Name 'daznelimgene lisbac' for OST-HER2 from World Health Organization
newsfilecorp.com
OSTX
Stonegate Capital Partners Updates Coverage on OS Therapies Inc. (OSTX) 3Q25
newsfilecorp.com
OSTX
OS Therapies to Spinoff OS Animal Health into Standalone Public Company
newsfilecorp.com
OSTX
DIS
OS Therapies Reports Third Quarter 2025 Financial Results and Provides Business Update
newsfilecorp.com
OSTX